Wave Life Sciences Ltd. (WVE) Financial Statements (2025 and earlier)

Company Profile

Business Address 7 STRAITS VIEW
SINGAPORE, 018936
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments200,35188,497150,564184,497147,161174,819
Cash and cash equivalents200,35188,497150,564184,497147,161174,819
Receivables 21,086  30,00020,00010,000
Prepaid expense9,9127,9326,58410,4349,626 
Other current assets4,0242,1085,4165,1118,689 
Other undisclosed current assets      17,454
Total current assets:235,37398,537162,564230,042185,476202,273
Noncurrent Assets
Operating lease, right-of-use asset22,63726,84318,37816,23218,101
Property, plant and equipment13,08417,28422,26629,19836,36839,931
Long-term investments and receivables     30,00050,000
Accounts and financing receivable, after allowance for credit loss     30,00050,000
Restricted cash and investments3,6993,6603,6513,6513,6473,625
Other undisclosed noncurrent assets1566214811510,658111
Total noncurrent assets:39,57647,84944,44349,19698,77493,667
TOTAL ASSETS:274,949146,386207,007279,238284,250295,940
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,60720,43121,03324,94122,76526,098
Employee-related liabilities10,1819,0038,6627,507
Accounts payable12,83916,9157,28113,7959,07313,089
Accrued liabilities1,7683,5163,5712,1435,0305,502
Deferred revenue150,05931,55837,09891,56089,652
Debt     3,243 
Deferred rent credit      115
Contract with customer, liability100,945
Other undisclosed current liabilities21,77419,5326,0704,5392,4932,883
Total current liabilities:186,44071,52164,201121,040118,153130,041
Noncurrent Liabilities
Long-term debt and lease obligation:   24,95525,59129,304 
Liabilities, other than long-term debt41,005112,08277,47941,95565,18775,430
Deferred revenue15,60179,77477,47941,48163,466
Contract with customer, liability68,156
Deferred rent credit      5,132
Other liabilities  190 4741,7212,142
Operating lease, liability25,40432,11824,95525,59129,304
Other undisclosed noncurrent liabilities      9,247
Total noncurrent liabilities:41,005112,082102,43467,54694,49184,677
Total liabilities:227,445183,603166,635188,586212,644214,718
Temporary equity, carrying amount7,8747,8747,8747,8747,8747,874
Equity
Equity, attributable to parent39,630(45,091)32,49882,77863,73273,348
Common stock935,367802,833749,851694,085539,547375,148
Additional paid in capital129,237119,44287,98071,57357,27737,768
Accumulated other comprehensive income (loss)(124)(29)181389267153
Accumulated deficit(1,024,850)(967,337)(805,514)(683,269)(533,359)(339,721)
Total equity:39,630(45,091)32,49882,77863,73273,348
TOTAL LIABILITIES AND EQUITY:274,949146,386207,007279,238284,250295,940

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues113,3053,64940,96420,07715,98314,414
Gross profit:113,3053,64940,96420,07715,98314,414
Operating expenses(181,301)(166,369)(167,980)(173,454)(224,300)(173,937)
Other undisclosed operating loss      
Operating loss:(67,996)(162,720)(127,016)(153,377)(208,317)(159,523)
Nonoperating income9,8061,5784,5672,62614,67912,939
Investment income, nonoperating7,9281,571305844,9123,368
Other nonoperating income1,87874,5372,0589,7389,549
Loss from continuing operations before income taxes:(58,190)(161,142)(122,449)(150,751)(193,638)(146,584)
Income tax expense (benefit) 677(681)204841 (69)
Loss from continuing operations:(57,513)(161,823)(122,245)(149,910)(193,638)(146,653)
Loss before gain (loss) on sale of properties:(122,245)(149,910)(193,638)(146,653)
Net loss available to common stockholders, diluted:(57,513)(161,823)(122,245)(149,910)(193,638)(146,653)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(57,513)(161,823)(122,245)(149,910)(193,638)(146,653)
Other comprehensive income (loss)(95)(210)(208)12211437
Other undisclosed comprehensive loss      
Comprehensive loss:(57,608)(162,033)(122,453)(149,788)(193,524)(146,616)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive loss, net of tax, attributable to parent:(57,608)(162,033)(122,453)(149,788)(193,524)(146,616)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: